Security key
74907L300
Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX)
CUSIP: 74907L300
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S
- Total 13F shares
- 220,073
- Total 13F value
- $127,678
- Share change
- +25,922
- SEC-reported price per share
- $0.58
- Number of holders
- 10
- Value change
- -$10,488
- Number of buys
- 8
- Number of sells
- 4
- Shares outstanding
- 9,352,472
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
10
Top holders
10
QNRX full security history
Ownership snapshot
Full 13F holder table
Quoin Pharmaceuticals, Ltd. SEC filings
Quoin Pharmaceuticals, Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Altium Capital Management...
Disclosed value leader
Altium Capital Management...
Comparable rows
8/8
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 0.71%
Showing 1-6 of 8 holder rows.
Quick read
Altium Capital Management LLC leads the comparable SEC ownership view at 0.71%.
8 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Altium Capital Management LLC's linked filing trail.
Comparable ownership
Top 5
Altium Capital Management LLC
0.71%
RENAISSANCE TECHNOLOGIES LLC
0.5%
Virtu Financial LLC
0.33%
HRT FINANCIAL LP
0.32%
CITADEL ADVISORS LLC
0.12%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Altium Capital Management LLC |
13F
Company
|
0.71%
|
$62,928
66,240 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.5%
|
$44,000
46,513 shares
|
— | 31 Mar 2024 |
| Virtu Financial LLC |
13F
Company
|
0.33%
|
$29,000
30,749 shares
|
— | 31 Mar 2024 |
| HRT FINANCIAL LP |
13F
Company
|
0.32%
|
$28,000
30,314 shares
|
— | 31 Mar 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.12%
|
$10,226
10,786 shares
|
— | 31 Mar 2024 |
| UBS Group AG |
13F
Company
|
0.05%
|
$4,850
5,105 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
220,073
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
8
Q2 2024 holders
10
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|